Dr. Jessica Justman's work at the Mailman School is focused on the University Technical Assistance Program (UTAP), which supports HIV care and treatment in four East African countries. UTAP is part of the School's International Center for AIDS Care and Treatment Programs (ICAP), and provides technical assistance in health systems development and HIV programs, such as linking TB and HIV care. Dr. Justman is also Associate Director of CIDER** and supervises doctoral students in their research. Prior to joining the Mailman School faculty, Dr. Jessica Justman was an infectious disease attending at Bronx-Lebanon Hospital Center for 10 years, where she gained extensive clinical experience in HIV, TB, and other infectious diseases in an inner-city setting. Dr. Justman has been involved in various clinical research studies. She was the principal investigator of the Bronx-Lebanon HIV Prevention Trials Network (www.HPTN.org) site, which completed two preliminary safety studies of vaginal microbicides in New York. Dr. Justman will continue her work with the HPTN as co-chair of an extended safety microbicide study which will enroll women from the Bronx and from India. Since 1994, Dr. Justman also has worked with the Women's Interagency HIV Study (WIHS http://statepiaps.jhsph.edu/wihs) an ongoing, study of over 2,700 HIV-infected women from six urban sites in the U.S. She has been interested in the metabolic side-effects of HIV and published the first prospective study on the association between protease inhibitors and the incidence of diabetes. She has also co-authored several other recent publications on metabolic side-effects and HIV.
Areas of Expertise
Tuberculosis, Hepatitis, HIV/AIDS, Infectious Disease, Underserved Populations, Women's Health, Contraception, Research Design and Methods
Select Global Activities
International Center for AIDS Care and Treatment Programs (ICAP), Mozambique;Rwanda;South Africa;Tanzania: As ICAP's Senior Technical Director, Dr. Justman oversees the clinical and monitoring and evaluation activities of ICAP's HIV prevention, care and treatment programs. She also directs ICAP?s student activities.
Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E, Lu D, Williams T, Wichienkuer P, Anastos K Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women JAIDS in press 2004
Tien PC, Kovacs A, Bacchetti P, French AL, Augenbraun M, Cole SR, Hessol N, Justman J Association of syphilis, antibodies to herpes simplex virus type 2, and recreational drug use with hepatitis B virus infection in the Womenâ€™s Interagency HIV Study Clin Infect Dis in press 2004
Tien PC, Cole SR, Williams CM, Li R, Justman J, Cohen MH, Young M, Rubin N, Augenbraun M, Grunfeld C Incidence of lipoatrophy and lipohypertrophy in the Womenâ€™s Interagency HIV Study JAIDS 34 461-6 2003
Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE Penicillin resistance and other predictors of mortality on pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence Clin Infect Dis 29 321-7 1999
Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE, Blum S Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis Clin Infect Dis 25 666-670 1997
Justman JE, Koblavi-Deme S, Tanuri A, Goldberg A, Gonzalez LF, Gwynn CR. Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings. JAIDS S1 S30-3 2009
B. Cutler, J. Justman Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis. 11 685-97 2008
J.E. Justman, D.R. Hoover, Q. Shi , T. Tan, K. Anastos, P.C. Tien ,S.R. Cole, C. Hyman , R. Karim, K. Weber, S. Grinspoon Longitudinal anthropometric patterns among HIV-infected and â€“uninfected women. JAIDS 47 312-9 2008
K. H. Mayer, L. Maslankowski, F. Gai, W. El-Sadr, J. Justman, A. Kwiecien, B. Masse, S. Eshelman, C. Hendrix, K. Morrow, J. Rooney, L. Soto-Torres. Safety and tolerability of tenofovir vaginal gel in abstintent and sexually active HIV-infected and uninfected women. AIDS 20 543 2006
Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM, Weber K, Piessens E, Robison E, Anastos K Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women JAIDS 32 298-302 2003